Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment
about
Virtual Surgical Planning for Orbital ReconstructionRituximab in the Treatment of Thyroid Eye Disease: A ReviewA musculoskeletal model of low grade connective tissue inflammation in patients with thyroid associated ophthalmopathy (TAO): the WOMED concept of lateral tension and its general implications in disease.Pingmu Decoction Induces Orbital Preadipocytes Apoptosis In VitroHuman TSH receptor ligands as pharmacological probes with potential clinical applicationUpdate on the medical treatment of Graves' ophthalmopathyImmunopathogenesis of thyroid eye disease: emerging paradigmsEvidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surfaceGraves' ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease.The eye and thyroid disease.Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy.Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis)Thyroid hormones increase collagen I and cartilage oligomeric matrix protein (COMP) expression in vitro human tenocytes.Orbital positron emission tomography/computed tomography (PET/CT) imaging findings in Graves ophthalmopathyIndependent adipogenic and contractile properties of fibroblasts in Graves' orbitopathy: an in vitro model for the evaluation of treatments.Thyroid associated orbitopathy.Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathyMechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptor18-Fluorodeoxyglucose Uptake by Positron Emission Tomography in Extraocular Muscles of Patients with and without Graves' OphthalmologyEfficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?Neuromuscular complications of thyrotoxicosis.Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies.Update on advanced imaging options for thyroid-associated orbitopathy.Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathyOcular myositis: diagnostic assessment, differential diagnoses, and therapy of a rare muscle disease - five new cases and reviewOrbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype.Therapeutic use of mini-scleral lenses in a patient with Graves' ophthalmopathyIcariin Inhibits AMPK-Dependent Autophagy and Adipogenesis in Adipocytes In vitro and in a Model of Graves' Orbitopathy In vivo.Thyroid hormones and tendon: current views and future perspectives. Concise review.Latent Pathways Identification by Microarray Expression Profiles in Thyroid-Associated Ophthalmopathy Patients.Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.Orbital Decompression for Thyroid Eye Disease.The effect of orbital radiation therapy on thyroid-associated orbitopathy complicated with dysthyroid optic neuropathy.Painless orbital myositisComputer-Assisted Three-Dimensional Planning for Orbital Decompression.Graves' disease associated with primary systemic sclerosis.Interleukin-7 expression in tears and orbital tissues of patients with Graves' ophthalmopathy.
P2860
Q26773922-F59A2D0C-773D-44B3-85A5-B3366368EE90Q28081573-055FF864-F357-41CF-8EF6-91FCC4ADB55CQ30830185-3A61CC99-36DE-47C2-8F3C-F0C06645A109Q33623928-84846A16-3B3F-4DFA-B293-DCA40C980C12Q33640737-EE97E71A-EB33-4D09-9BF2-8D625660AF47Q33735061-9EBF2DC9-C8D7-4F2C-A63B-ABB12DAB51F2Q33789467-B774F5E0-5299-47DB-8A94-C3444742363AQ33801404-C51EA481-A347-4514-A9CB-0D483C3CA005Q33802192-3DB145C2-E4A9-4FB0-9D78-C909AA27089DQ33827155-BE4261BF-CE35-4E32-8187-5DFE882A1A9BQ34014090-A7C362C1-6DE5-4786-B82C-1A21954DE2EEQ34062319-A3C0B24A-3B39-4D97-8080-A5E0A8CC0B9DQ34525298-981A3494-EF98-4904-AB11-6427E86422D4Q34561159-BCC0714C-FDB9-405D-AD69-E72858132004Q34978981-B0C3DA90-19CB-4A0D-8404-098821EF7D48Q35154018-55A2A279-44A0-4435-A3CE-917322C86F7EQ35919247-C84A1CEE-1E69-45E4-921A-86788097918CQ36051587-EDEE1765-1F4C-4787-B494-0332E75B33CEQ36147341-7AB7F10A-39D1-446C-A422-60F3815A8E57Q36651346-15A63276-8B9B-4220-BE5B-DA70DE74F139Q36794149-BB2C1859-640D-496F-A881-3C1DEB201A50Q36830207-88CEA1CA-8074-4729-91F4-1DC38DC7FA68Q36846744-A1015A81-1BE1-4705-AA4B-681F412C425BQ36970632-B077BC50-7CD3-4EE9-A881-5DF39F3D210FQ37060099-BFCE3DB3-2019-4F7A-AD33-BAC51C94D408Q37104648-C4C66A9E-56C4-4164-AA6F-74B2855D9203Q37236634-CF9B9F00-0594-41E1-9E8C-626B0C6203B0Q37296579-71362C9E-C2B2-4976-8FFA-68CBB43CCB28Q37473336-B9771BE2-1E8F-4F85-969F-9B708C46878EQ37610397-DE989BF4-50E5-4F48-8C36-69A8F251D148Q37637484-9C27B1D0-8A4B-463B-8BD1-56C861F2172DQ38173766-F7C81A8C-9651-42CD-897E-07EAB329EB0BQ38463028-18B25467-03F0-46E2-BFE2-BB1FA2CDD2ECQ38633022-6D6AB1C7-0952-4071-BFEA-196884578F05Q39159003-58108017-0299-42D2-AE73-3B500D7E62F9Q39303459-7C247DC7-895D-4A52-BA56-FFFFA452CF3CQ42064302-A04CE4CF-D082-427B-B02E-CA41F77410BCQ42433372-2FE55FD5-2790-4E31-94AD-B347F3C9720CQ43258976-389D65FA-7820-4D44-961B-1E781B2880CCQ43836223-A7E4A306-0848-4858-9976-135886C9B68C
P2860
Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pathogenesis of graves ophthal ...... ion, prevention, and treatment
@ast
Pathogenesis of graves ophthal ...... ion, prevention, and treatment
@en
type
label
Pathogenesis of graves ophthal ...... ion, prevention, and treatment
@ast
Pathogenesis of graves ophthal ...... ion, prevention, and treatment
@en
prefLabel
Pathogenesis of graves ophthal ...... ion, prevention, and treatment
@ast
Pathogenesis of graves ophthal ...... ion, prevention, and treatment
@en
P2860
P1476
Pathogenesis of graves ophthal ...... ion, prevention, and treatment
@en
P2093
James A Garrity
Rebecca S Bahn
P2860
P304
P356
10.1016/J.AJO.2006.02.047
P407
P577
2006-07-01T00:00:00Z